+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Isoacteoside

BP0770
61303-13-7
98%
Phytopurify
Isoacteoside exhibits significant inhibition of advanced glycation end product formation with IC50 values of 4.6-25.7 μM; it has neuroprotective, antioxidant, and anti-inflammatory effects. Isoacteoside can stimulate the increase of α7 and α3 proteins in the cultured cells, attenuate the decreased expression of α3 and α7 nAChR subunit proteins and cell viability on SH-SY5Y cells induced by Aβ; it can regulate caspase-1, mitogen-activated protein kinases (c-Jun N-terminal kinase, p38, extracellular signal-regulated protein kinase) and nuclear factor-kappa B pathways.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0770-20mg 20mg
BP0770-100mg 100mg
BP0770-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related diseases

Related targets

BACE1 MAPT SNCA APOE PSEN1

Isoacteoside Related Products

Product drug property prediction parameters

  • 245.2900

  • .2832

  • .2718

  • 4.7536

  • .4993

  • .0882

  • Low

  • 73.5420

  • 4.7080

  • Yes

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • Yes